Jul 292020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, PA – Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced the appointment of Charles Austin to its Board of Directors. “We are delighted that Chuck will be joining the board, and we feel confident ...

Marinus Pharmaceuticals welcomes Chuck Austin to its Board of Directors

Marinus Pharmaceuticals welcomes Chuck Austin to its Board of Directors

From:: Marinus Pharmaceuticals welcomes Chuck Austin to its Board of Directors

Sorry, the comment form is closed at this time.